Crossmark

Successful treatment of rituximab-refractory pemphigus vulgaris with Obinutuzumab

Crossref DOI link: https://doi.org/10.1016/j.abd.2026.501457

Published Print: 2026-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Saraç, Muhammet Talha https://orcid.org/0009-0001-7459-2729
Aygün Alizada, Merve

Erol Mart, Handan Merve

Boyvat, Ayşe

Şanlı, Hatice

Öktem, Ayşe
Funding

Funding for this research was provided by:

Ankara University
License Information

Text and Data Mining valid from 2026-09-01

Text and Data Mining valid from 2026-09-01

Version of Record valid from 2026-08-11
More Information

This article is maintained by: Elsevier

Article Title: Successful treatment of rituximab-refractory pemphigus vulgaris with Obinutuzumab

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2026.501457

Content Type: article

Copyright: © 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.